ScholarIQanswers from OpenAlex

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma

PaperCitations, authors & open-access status

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma have?

ScholarIQcitation count

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma has 30 citations in the OpenAlex counts ScholarIQ stores.

When was YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma published?

ScholarIQyear

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma has 2021 year in the ScholarIQ index.

What is the open-access status of YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma?

ScholarIQoa status

YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma has gold oa status in the ScholarIQ index.

What is the DOI of YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma?

ScholarIQdoi

The DOI for YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma is on the source record.

What is the PMID of YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma?

ScholarIQpmid

The PMID for YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma is on the source record.

What is the OpenAlex record for YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma?

ScholarIQopenalex

The OpenAlex for YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial